OrganiGram Holdings Stock (TSX: OGI) (NASDAQ: OGI) - Investor Dashboard


➔ OrganiGram Holdings
TSX Exchange: OGI
NASDAQ Ticker: OGI
Market Focus: Canada
Classification: Vertically Integrated
Country: Canada
Employees: 816 at 02/29/20
Established: 2013
CEO: Greg Engel

Summary

Fiscal Year-End:  August
Facilities:  1
Dried Flower: Production and Sale
Extracts: Production and Sale
Number of Patients:  17,000 (5/31/19)
Headquarters: Moncton, NB

Financials (05/31/20)

Cash on hand: $44.8 million
Fixed Investment: $249.7 million
Shareholders’ Equity: $320.2 million
Revenues – Last Quarter: $18.0 million
Adj. Gross Margin : -146.2%
EPS : -$0.512

Capital Structure (07/17/20)

Last Financing:  21.0 million shares at C$2.33 average
Basic Shares: 194.5 million
Warrants: 0
Options: 9.1 million
Diluted Shares: 204.6 million

Company Brief

Organigram Holdings Inc. is a NASDAQ and TSX Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing the highest-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the company’s global footprint.

Organigram has developed a portfolio of brands including The Edison Cannabis Company, Ankr Organics, Trailer Blazer, and Trailer Park Buds. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations.

Featured Videos


Highlights

  • One of the few licensed producers east of Ontario
  • Industry-leading yields
  • Target annual production capacity of 70,000 kilograms
  • Complete portfolio of consumer brands including Trailblazer, Trailer Park  Buds, Ankr Organics, Edison Cannabis Co., and Edison Cannabis Co. Reserve
  • Supply agreements with 10 provinces
  • Partnerships with The Green Solution  and Valens GroWorks for edibles and derivatives
  • Supply agreement with Medical Cannabis by Shoppers, an online medical cannabis platform

Growth Strategy

  • Continuing to grow in the medical market while gaining share in the adult consumer market with a robust portfolio of brands and formats
  • Pursuing the acquisition of hemp-related production assets and seeking partnerships for international CBD markets
  • Plans to focus on the vaporizer market;  partnership with PAX Era and selected as exclusive Canadian supplier of Feather Company’s vaporizer hardware
  • Development of a 10-15 minute onset beverage formulation using proprietary nano-emulsification technology; seeking a strategic partner for beverage product development
  • Investment in high-speed, fully automated production line for chocolate cannabis-infused edibles
  • Multi-year supply agreement with Israeli medical cannabis producer Canndoc

Differentiators

  • Based in New Brunswick makes the company one of the few located east of Quebec, with bilingual branding and services
  • Management team with extensive experience in cannabis and other key industries
  • Scalable production facilities on 14 acres of land with three-level growing technology that allows it to maximize its footprint
  • Dealer’s License since May 2018, allowing it to develop, test and export an extensive range of products; Health Canada research license
  • Investment in cannabinoid science and biosynthesis company Hyasynth Biologicals and hemp-based consumer healthcare product company Eviana
  • Agreement with industrial hemp research company 1812 Hemp to support R&D on improving hemp yields and costs

Adult Recreational Portfolio


Institutional Analyst Coverage

MATT BOTTOMLEY
Canaccord

Russell Stanley, MBA
Echelon Wealth Partners

JESSE PYTLAK, CFA,
Cormark Securities

PABLO ZUANIC
Cantor Fitzgerald

GREG MCLEISH, CFA
Mackie Research

MARTIN LANDRY, CPA
GMP Securities

NEAL GILMER
Haywood Securities

JASON ZANDBERG, CFA
PI Financial


Curated Stories & News


Visit OrganiGram Holdings
at www.organigram.ca.

New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. OrganiGram Holdings is a client of NCV Media, LLC. Read our full disclaimer.